In a myeloproliferative neoplasms model, CUR activates the JAK2/STAT pathway, inducing apoptosis and inhibiting proliferation, thus exerting an antitumor effect on human JAK2-mutated cells (75). The gene discussed is JAK2; the disease is myeloproliferative disorder.